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Abstract
Background
Observational studies on pubertal timing and asthma, mainly performed in females, have
provided conflicting results about a possible association of early puberty with higher risk of
adult asthma, possibly due to residual confounding. To overcome issues of confounding, we
used Mendelian randomisation (MR), i.e., genetic variants were used as instrumental vari-
ables to estimate causal effects of early puberty on post-pubertal asthma in both females
and males.
Methods and findings
MR analyses were performed in UK Biobank on 243,316 women using 254 genetic variants
for age at menarche, and on 192,067 men using 46 variants for age at voice breaking. Age
at menarche, recorded in years, was categorised as early (<12), normal (12–14), or late
(>14); age at voice breaking was recorded and analysed as early (younger than average),
normal (about average age), or late (older than average). In females, we found evidence for
a causal effect of pubertal timing on asthma, with an 8% increase in asthma risk for early
menarche (odds ratio [OR] 1.08; 95% CI 1.04 to 1.12; p = 8.7 × 10−5) and an 8% decrease
for late menarche (OR 0.92; 95% CI 0.89 to 0.97; p = 3.4 × 10−4), suggesting a continuous
protective effect of increasing age at puberty. In males, we found very similar estimates of
causal effects, although with wider confidence intervals (early voice breaking: OR 1.07; 95%
CI 1.00 to 1.16; p = 0.06; late voice breaking: OR 0.93; 95% CI 0.87 to 0.99; p = 0.03). We
detected only modest pleiotropy, and our findings showed robustness when different meth-
ods to account for pleiotropy were applied. BMI may either introduce pleiotropy or lie on the
causal pathway; secondary analyses excluding variants associated with BMI yielded similar
results to those of the main analyses. Our study relies on self-reported exposures and out-
comes, which may have particularly affected the power of the analyses on age at voice
breaking.
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Conclusions
This large MR study provides evidence for a causal detrimental effect of early puberty on
asthma, and does not support previous observational findings of a U-shaped relationship
between pubertal timing and asthma. Common biological or psychological mechanisms
associated with early puberty might explain the similarity of our results in females and
males, but further research is needed to investigate this. Taken together with evidence for
other detrimental effects of early puberty on health, our study emphasises the need to fur-
ther investigate and address the causes of the secular shift towards earlier puberty
observed worldwide.
Author summary
Why was this study done?
• Worldwide there has been a shift towards earlier puberty over time, possibly due to
changes in childhood lifestyle and levels of adiposity.
• Early puberty has been linked to an increased risk of asthma in women, but findings are
inconsistent across studies, and little research has been done in men.
• There is some suggestion that late puberty might also increase the risk of asthma.
• Studies performed so far have some methodological limitations that make it difficult to
distinguish true effects from spurious findings.
What did the researchers do and find?
• We studied the effect of age at puberty on asthma in women and men using Mendelian
randomisation, an approach that exploits genetic data to overcome some limitations of
classical observational studies.
• From the UK Biobank study, we analysed data on approximately 240,000 women and
approximately 190,000 men with available genetic data and self-reported information
on asthma and age at puberty (menarche for women and voice breaking for men).
• We found that women and men with early puberty had an increased risk of asthma of
8% and 7%, respectively.
• We found no evidence of a detrimental effect of late puberty on asthma.
What do these findings mean?
• These findings, together with suggestions of other detrimental effects of early puberty
on health, emphasise the importance of evaluating the overall evidence on health effects
of early puberty.
Age at puberty and risk of asthma: A Mendelian randomisation study
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002634 August 7, 2018 2 / 14
by the Medical Research Council (MC_UU_12013/
1).
Competing interests: I have read the journal’s
policy and the authors of this manuscript have the
following competing interests: CM and GDS are
members of the Editorial Board of PLOS Medicine.
Abbreviations: 2SLS, 2-stage least squares; AAO,
age at onset; GWA, genome-wide association;
IVW, inverse-variance weighted; MR, Mendelian
randomisation; OR, odds ratio; SNP, single
nucleotide polymorphism.
• The similarity of findings in females and males might be explained by common biologi-
cal or psychological factors related to early puberty, but further research is needed to
investigate this.
Introduction
Asthma is one of the most common chronic diseases in children and adults, and its prevalence
has been increasing worldwide [1]. Multiple risk factors for asthma have been proposed, but
one of the few consistent observations is sex differences in disease prevalence. Understanding
the reason for these differences could lead to the identification of modifiable factors that could
be targeted by preventive measures [2].
Sex differences in asthma prevalence are age dependent, with a switch from male predomi-
nance in childhood to female predominance from adolescence onwards [3,4]. It has been
hypothesized that the higher prevalence of post-pubertal asthma in females, with higher inci-
dence and lower remission rates [4], might be due to a pathogenetic role of female sex hor-
mones [3,5]. This is further supported by observational findings of an association of early
menarche with increased risk of post-pubertal asthma [6]. In addition to the hypothesis of sex
hormones mediating the effect of early menarche on asthma, another proposed mechanism is
through obesity: Early menarche would increase the risk of adult obesity, which would in turn
affect asthma, possibly through an effect of higher leptin levels on the immune system and air-
way inflammation, although it could be the other way round, with higher childhood BMI and
leptin increasing the risk of early menarche, which would increase the risk of asthma [7,8].
Despite the plausibility that the observed association of early menarche with asthma may rep-
resent a causal effect, this cannot be concluded based on the available evidence, and, if there is
a causal effect, it is unclear what its magnitude may be. A meta-analysis of 7 observational
studies suggested a 37% increase in asthma risk for women with menarche before the age of 12
years, but there was substantial heterogeneity in results across studies [9]. The meta-analysis
was mainly based on young study populations, and an observational study in UK Biobank
including women aged 40 to 69 years suggested a smaller increase of 6% in asthma risk after
adjustment for confounders [10]. The same study also showed an association in males, with an
11% increase in risk associated with early voice breaking, a marker of male puberty, and it sug-
gested a U-shaped relationship in females and males, with an increased risk of asthma associ-
ated with both early and late puberty [10]. More recently, a prospective study in women up to
the age of 60 years suggested no association after extensive adjustment for confounders [11].
The possibility of residual confounding by unmeasured factors, including intrauterine expo-
sures as well as childhood diet, lifestyle and socioeconomic status, limits the interpretation of
these findings and may explain inconsistencies across studies. There is also a potential problem
of reverse causation, as there are some data suggesting that girls with childhood asthma might
have earlier menarche [12]. This could generate spurious associations, particularly if study par-
ticipants with pre-pubertal asthma were not excluded from the analyses due to poor recall of
their childhood symptoms.
The Mendelian randomisation (MR) approach applied here uses genetic variants known to
affect age at puberty as proxies (instrumental variables) to derive estimates of the effect of age
at puberty on asthma [13]. As genes are randomly allocated at the time of conception, genetic
associations are not affected by typical confounding factors or reverse causation, and MR can
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provide indirect evidence for a causal effect if its underlying assumptions hold [13,14]. Here
we describe a large MR study in UK Biobank aimed at estimating the causal effect of age at
puberty on the risk of post-pubertal asthma in females and males.
Methods
The UK Biobank is a prospective study of about 500,000 adults aged 40–69 years recruited in
2006–2010 across 22 centres, aimed at identifying causes of chronic disease in middle and old
age [15]. About 95% of the participants are white. Data on doctor-diagnosed asthma and age at
onset (AAO), age at menarche in females, and age at voice breaking in males are all based on
self-reports from questionnaires. The specific questions used to define the variables used are
reported in Table 1, together with the UK Biobank data-field number for access to further
information on measurement procedures through the UK Biobank webpage (http://biobank.
ctsu.ox.ac.uk/crystal/search.cgi). While age at menarche was recorded in years, age at voice
breaking was recorded as a 3-level categorical variable (at a younger, average, or older age
compared to peers). In order to increase comparability with the findings in males, we catego-
rised age at menarche in females as early (<12 years), normal (12 to 14), or late (>14), using
“normal” as the reference. This also allowed the investigation of possible non-linear associa-
tions, such as U-shaped relationships. In females, we defined post-pubertal asthma as asthma
occurring after menarche; in males, this was defined as asthma occurring after the age of 15
years. Participants with pre-pubertal asthma were excluded from the analyses.
Choice of instruments for MR analyses
We chose MR instruments for age at menarche based on findings from the large genome-wide
association (GWA) meta-analysis by Day et al. [16], which included 329,345 women of
Table 1. Characteristics of the study population, for females and males.
Variable Females
(N = 243,316)
Males
(N = 192,067)
Definition
Age (years) 56.4 (8.0) 56.8 (8.2) Age at assessment [data-field 21003]
Age at menarche
(years)
13.0 (1.6) Self-reported (“How old were you when your periods started?”) [data-field 2714]
Early (<12) 48,840 (20.1)
Normal (12–14) 153,727 (63.2)
Late (>14) 40,749 (16.7)
Voice breaking Self-reported (“When did your voice break?”) [data-field 2385]
Early (younger than
average)
8,353 (4.3)
Normal (about
average age)
172,604 (89.9)
Late (older than
average)
11,110 (5.8)
BMI (kg/m2) 27.0 (5.1) 27.8 (4.2) Calculated from measured height and weight [data-field 21001]
Asthma 22,295 (9.2) 12,066 (6.3) Self-reported doctor-diagnosed asthma (“Has a doctor ever told you that you have asthma?”) [data-field 6152
(all participants) + data-field 22127 (subset from online occupational follow-up)]1
Asthma AAO (years) 39.7 (13.4) 41.0 (13.1) Self-reported (“What was your age when the asthma was first diagnosed?”) [data-field 3786]
Reported are mean (SD) for continuous variables and N (%) for categorical variables. Only post-pubertal asthma is considered. Data-field: UK Biobank variable’s
identifier (link to further information through website: http://biobank.ctsu.ox.ac.uk/crystal/search.cgi). Asthma and age at onset (AAO) refer to post-pubertal asthma.
1Asthma was considered present if there was a positive answer in either of the 2 data-fields.
https://doi.org/10.1371/journal.pmed.1002634.t001
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European ancestry from the ReproGen consortium (40 studies, N = 179,117), 23andMe (N =
76,831), and UK Biobank (N = 73,397). In all, 389 independent single nucleotide polymor-
phisms (SNPs) were identified at a genome-wide significant level (p< 5 × 10−8), explaining
overall 7.4% of the population variance in age at menarche. Of the reported 389 SNPs, 372
were available (or had a proxy, linkage disequilibrium r2 > 0.7) in UK Biobank.
The instrument strength of each SNP for both early and late menarche was assessed using
the F statistic, a function of the magnitude and precision of the SNP’s effect on menarche [17].
To avoid bias associated with the use of weak instruments, we excluded SNPs with a low F sta-
tistic in UK Biobank, using the common threshold of 10 [18]. This left us with 206 and 151
SNPs (254 in total) as instruments for early and late menarche, respectively; F statistic values
varied from 10.1 to 382.5 for early menarche and from 10.0 to 150.0 for late menarche (S1
Table). All SNPs had good imputation quality (info score > 0.8).
In the GWA meta-analysis by Day et al. [16], 127 of the 389 age-at-menarche SNPs were
also associated in the same direction with age at voice breaking at nominal significance level;
of these, only 40 were strong instruments (F statistic > 10) for either early or late puberty in
males. In order to increase our number of instruments, we searched the literature for addi-
tional genetic studies on age at voice breaking, using the NHGRI GWAS Catalog [19] and
HuGE Navigator [20], as well as crosschecking of references. We identified 3 other GWA stud-
ies [21–23], 2 of which added new independent SNPs, the studies by Day et al. [22] and by
Pickrell et al. [23] (S2 Table). After combining all SNPs and excluding weak instruments, 24
and 37 SNPs (46 in total) remained for the MR analyses of early and late voice breaking,
respectively. Their F statistic values varied from 10.2 to 52.4 for early voice breaking and from
10.8 to 101.6 for late voice breaking (S2 Table). All SNPs had good imputation quality (info
score > 0.9). All 46 SNPs were independent, except for 3 pairs of correlated SNPs (linkage dis-
equilibrium r2 of 0.3, 0.6, and 0.6). As a post hoc analysis to investigate the impact of the corre-
lation between these SNPs on our MR results, we used the method by Burgess et al., which
accounts for the correlation between instruments [24].
Details on genotyping and imputation methods and quality control procedures in UK Bio-
bank are available elsewhere [25].
MR methods
In 1-sample MR investigations (where the genetic associations with both risk factor and out-
come are estimated within the same study), the standard MR approach is the 2-stage least
squares (2SLS) method: the risk factor is regressed jointly on all SNPs, and the outcome is
regressed on the genetically predicted values of the risk factor from the first regression [26]. As
this method does not account for pleiotropy (where SNPs chosen as instruments for the risk
factor affect the outcome through additional independent pathways [14]) and we cannot rule
out the possibility of pleiotropic effects for some of our SNPs, we used methods developed for
2-sample MR. Here estimates of the genetic associations with risk factor and outcome are
obtained separately for each SNP. If all SNPs are valid instruments (e.g., no pleiotropy) and
linear models with no interactions faithfully describe the SNP–risk factor and risk factor–out-
come relationships [27], the individual MR estimates of causal effect will vary only by chance,
with no between-instrument heterogeneity [28]. For each SNP, the association with early or
late menarche/voice breaking (G–X, expressed as log odds ratio [OR]) and the association
with asthma (G–Y, log OR) were estimated using multiple logistic regression adjusted for
assessment centre, first 10 ancestry principal components, and genotyping array. It should be
noted that with binary variables the linearity assumption is strictly violated [29], but in practice
the magnitude of the bias has been shown to be negligible [30].
Age at puberty and risk of asthma: A Mendelian randomisation study
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An MR estimate was obtained for each SNP using a Wald estimator (ratio of G–Y over G–
X), with standard error derived using the Delta method [31], and individual MR estimates
were pooled using inverse-variance weighted (IVW) fixed-effect meta-analysis [32]. The
pooled MR estimate is asymptotically equal to the MR estimate obtained with the 2SLS method
[32], which we also performed as a sensitivity analysis. Since the IVW fixed-effect meta-analy-
sis method assumes no pleiotropy, we performed secondary analyses using approaches based
on different assumptions about pleiotropy across SNPs: (1) IVW random-effect meta-analysis,
assuming random pleiotropic effects (i.e., they cancel out) [33]; (2) MR-Egger regression with
penalised weights, assuming directional pleiotropic effects [34]; and (3) weighted median anal-
ysis, assuming that at least 50% of the SNPs are valid instruments (but with no assumption
about direction of pleiotropic effects) [35].
Some of the genetic variants associated with pubertal timing are also associated with BMI
[16], and this may complicate the interpretation of the results given that BMI could either
introduce pleiotropy (i.e., affecting asthma independently from age at puberty) or lie on the
causal pathway. In secondary analyses we therefore excluded SNPs associated with BMI from
our instruments. We identified SNPs associated with BMI, overweight, or obesity in previous
GWA studies from PhenoScanner, a database of publicly available GWA findings (http://
www.phenoscanner.medschl.cam.ac.uk/phenoscanner) [36], using a significance threshold
corrected for multiple testing, p< 2.0 × 10−4 (0.05/254) for menarche SNPs and p< 1.1 × 10−3
(0.05/46) for voice breaking SNPs.
To provide further support for the absence of pleiotropy, we used pre-pubertal asthma as a
“negative control” outcome [37]. If our instruments affect asthma solely through age at menar-
che/voice breaking, we expect to find no effect on asthma developed before puberty.
There was no formal pre-specified protocol for this study; all the analyses described above
were decided a priori, and we performed additional post hoc analyses suggested by the review-
ers. In particular, sensitivity analyses were carried out to assess the robustness of the results to
the use of different AAO cutoffs for post-pubertal asthma definition in males, and to the pres-
ence of some correlation between genetic variants. Subgroup analyses were also performed to
investigate the possibility that the effect of age at puberty on asthma might be modified by
whether or not one is overweight.
All analyses were performed using Stata 15 (StataCorp).
Results
The characteristics of the study population are summarised in Table 1. We included 243,316
women and 192,067 men with available genetic data and information on age at puberty,
asthma and AAO; post-pubertal asthma was present in 22,295 (9.2%) women and 12,066
(6.3%) men. Asthma prevalence by category of age at puberty was 10.4% for early, 8.9% for
normal, and 8.8% for late menarche in females, and 7.5% for early, 6.2% for normal, and 7.1%
for late age at voice breaking in males.
MR analyses
Detailed results from all MR analyses are reported in S3 and S4 Tables, for females and males,
respectively. In females, we found evidence for a detrimental causal effect of early menarche,
with an OR of 1.08 (95% CI 1.04 to 1.12; p = 8.7 × 10−5), and for a protective causal effect of
late menarche, with an OR of 0.92 (95% CI 0.89 to 0.97; p = 3.4 × 10−4). This suggests a contin-
uous protective effect of increasing age at puberty, and does not support observational evi-
dence of a U-shaped relationship. When we repeated the analysis using age at menarche as a
continuous variable (332 SNPs with F> 10 as instruments), we found an OR of 1.06 (95% CI
Age at puberty and risk of asthma: A Mendelian randomisation study
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002634 August 7, 2018 6 / 14
1.03 to 1.11; p = 1.6 × 10−4) per year decrease in age at menarche. In males, we found an OR of
1.07 (95% CI 1.00 to 1.16; p = 0.064) for early and 0.93 (95% CI 0.87 to 0.99; p = 0.029) for late
voice breaking. The results remained the same in sensitivity analyses allowing for the correla-
tion between SNPs, and became slightly stronger in sensitivity analyses using higher age cut-
offs for asthma AAO to define post-pubertal asthma, specifically AAO >16 and>17 years (S4
Table). These findings in males are very similar to those in females, despite the much wider
confidence intervals reflecting the lower power of the analyses (fewer instruments available for
age at voice breaking and possibly larger measurement error). The use of a 1-sample 2SLS
approach gave similar results in both females and males (S3 and S4 Tables).
We found only modest between-instrument heterogeneity in females (I2 of 16% and 20%
for early and late puberty, respectively; S3 Table) and little evidence of heterogeneity in males
(I2 of 2% and 0%, respectively; S4 Table). The results of the analyses controlling for pleiotropy
were consistent with those of the main analyses (Fig 1), with differences in the precision of the
estimates in line with expected differences in statistical power [33,35]. MR-Egger regression in
males suggested stronger effects compared to the main analysis, particularly for early puberty
(Fig 1), but the confidence intervals were wide as the analysis had limited power. This low
power is due to the low number of SNPs and their relatively similar instrument strengths
(MR-Egger regression works best when there is a large spread of strengths [38]).
Secondary analyses with exclusion of SNPs associated with BMI (14 and 12 excluded for
early and late menarche; 5 and 7 excluded for early and late voice breaking) gave similar results
to those of the main analyses for both females and males (S3 and S4 Tables).
As the percentages of females in the early and late menarche categories were substantially
higher than the percentages of males in the corresponding categories (Table 1), we repeated
the analyses using more stringent cutoffs for age at menarche. Using a cutoff of<11 instead of
<12 years for early and>15 instead of>14 years for late menarche, the percentages were very
similar to those in males, 4.6% and 5.8% for early and late menarche, respectively. The results
were in line with those of the main analyses, with an OR of 1.06 (95% CI 1.02 to 1.09; p =
6.4 × 10−4) for early and 0.95 (95% CI 0.91 to 0.98; p = 0.002) for late menarche.
Fig 1. Estimates across different MR methods of the effects of early and late puberty on asthma risk in females
(menarche) and males (voice breaking). In red: main analysis. IVW, inverse-variance weighted; MR, Mendelian
randomisation.
https://doi.org/10.1371/journal.pmed.1002634.g001
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The MR analyses on pre-pubertal asthma, used as a negative control outcome, suggested no
effect for either age at menarche or age at voice breaking, further reassuring against effects of
our genetic instruments on asthma independent from pubertal timing.
Finally, we repeated the analyses separately by BMI group, with low/high BMI defined as
below/above the median (<26/26 kg/m2 in females; <27/27 kg/m2 in males), to investigate
possible effect modification due to whether or not participants are overweight. BMI data refer
to the participants’ BMI at the time of recruitment into UK Biobank (Table 1). In females,
these analyses (S3 Table) showed effect estimates for early and late menarche consistent with
the main analyses in the high BMI group, and no evidence for effects of early or late menarche
in the low BMI group, but there was no statistical evidence of interaction (p-values of 0.23 and
0.67 for tests of the difference in estimates between BMI groups for early and late menarche,
respectively). In males, there was no evidence of effect modification (S4 Table), as expected
given the very low statistical power.
Discussion
This MR study provides evidence for a detrimental causal effect of earlier age at puberty on the
risk of developing asthma later in life. In females, we estimated an 8% increase in asthma risk
for early menarche (<12 years) and an 8% decrease for late menarche (>14 years). A very sim-
ilar pattern was observed in males, with a 7% increase in risk for early puberty and a 7%
decrease for late puberty, although the evidence was weaker than in females due to the much
lower statistical power. Previous observational studies on pubertal timing and asthma, mainly
performed in females, provided conflicting results, possibly due to residual confounding,
reverse causation, or inappropriate adjustment for factors that lie on the causal pathway. This
study adds to current knowledge by providing evidence for a causal effect of early puberty on
asthma in both females and males, and by clarifying the pattern of the relationship between
pubertal timing and asthma. Previous observational analyses in UK Biobank [10] suggested
that there could be a U-shaped relationship (both early and late puberty would be detrimental),
but our MR study does not support this and suggests a continuous protective effect of increas-
ing age at puberty. The discrepancy may be due to confounding of the observational findings
by factors associated with both delayed puberty and increased risk of asthma.
The results of our post hoc analysis by BMI group are compatible with the possibility of a
stronger effect of age at puberty on asthma in overweight females, but these results have major
limitations that make it difficult to draw conclusions. Stratifying by BMI might introduce col-
lider bias, whereby conditioning on a common effect of exposure and outcome generates a
spurious association between the two [39]; BMI is indeed affected by some of the puberty
SNPs and might also be affected by asthma through medication side effects or reduced physical
exercise. Moreover, the power of these analyses in females is low, in particular to detect inter-
action, and even more so in males. Finally, in our analyses we could only use adult BMI;
although childhood obesity is likely to track to obesity in adulthood, the inability to disentan-
gle the two makes these analyses difficult to interpret. Further research using longitudinal data
is needed to investigate a possible role of obesity in modifying the effect of age at puberty on
asthma.
The similarity of effect estimates in females and males provides insight into possible under-
lying mechanisms. Previously reported associations of early menarche with asthma have been
hypothesized to be explained by earlier and greater cumulative exposure to female sex hor-
mones such as oestrogens or an unbalanced oestrogen/progesterone ratio [5,9], although
experimental evidence in mice does not support this explanation [40]. A role for female sex
hormones has also been suggested by a reported association between pregnancy, characterised
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by increased levels of progesterone and oestrogens, and asthma development [41], and by
decreased incidence of asthma after natural menopause [42,43]. The similarity of our results in
both sexes suggests that early menarche may affect asthma through mechanisms that go
beyond female sex hormones. Other factors accompanying early puberty in both females and
males could be responsible, including biological but also psychological factors, such as depres-
sion, anxiety, and psychosomatic symptoms [44]. Further investigation of these aspects is
important to identify modifiable factors that mediate the effects of early puberty on asthma
and other adverse health outcomes.
The effect estimates found in our large study are of modest magnitude and therefore of lim-
ited clinical relevance to an individual, but they have important implications at a population
level. In Europe, age at menarche decreased by 2 to 3 months per decade between 1790 and
1980 [45] and continued to decrease at a lower rate in the following decades [46], with similar
trends observed worldwide. Although the reasons for such a shift are not fully understood,
there is evidence suggesting a role for changing childhood risk factors, including diet and obe-
sity, psychological stress, and environmental exposures [47]. Childhood obesity is likely the
strongest potentially preventable factor, and currently represents a global epidemic, with half
of the world’s population predicted to be overweight or obese by 2030 [48]. Other environ-
mental risk factors for early puberty warrant further investigation, including endocrine-dis-
rupting chemicals found in many household products that are hypothesized to have
transgenerational epigenetic effects [49]. Observational evidence, particularly in females, has
suggested detrimental effects of early puberty on other health outcomes including lung func-
tion, BMI, cardiometabolic traits, cardiovascular disease, and cancer [10,50–55], with recent
support from MR analyses [16,22,56,57]. Taken together with this evidence, our findings
emphasise the importance of investigating modifiable risk factors for early puberty with the
aim of reversing the secular shift towards earlier puberty observed worldwide.
Strengths and weaknesses
MR is a valuable tool to assess causality in epidemiology as it is not affected by the classical
confounding factors or reverse causation typical of observational studies. However, this tech-
nique is at its most reliable and transparent in the absence of pleiotropy, i.e., in this case, where
the genetic instruments do not have direct effects on asthma independent of age at puberty
[14]. As the risk of pleiotropy is high in MR investigations where many SNPs of uncertain bio-
logical function are included, we thoroughly investigated its potential impact on our findings.
Obesity was identified a priori as a potential source of pleiotropic effects given its genetic over-
lap with pubertal timing, and in fact around 7% of our instruments for age at puberty were
also associated with BMI. In practice, what role BMI might play in our study is unclear, as it
could induce “horizontal” pleiotropy by affecting asthma independently from puberty, but it
could also lie on the causal pathway either preceding puberty (high childhood BMI! early
puberty! high asthma risk) or mediating its effects (early puberty! high adult BMI! high
asthma risk), which is referred to as “vertical pleiotropy” [58]. Only horizontal pleiotropy
would affect the validity of our MR findings. When excluding SNPs associated with BMI, we
found very similar results to those of the main analyses. Pleiotropy could act through mecha-
nisms other than obesity. We therefore investigated the likely magnitude of pleiotropy by
assessing the heterogeneity among causal estimates from the individual SNPs (no heterogene-
ity if all valid instruments [28]), and found evidence of only modest heterogeneity. This was
supported by the consistency in the findings from 3 different methods to adjust for pleiotropy
(IVW random-effect, weighted median, and MR-Egger regression) with those of the main
analyses. Finally, we repeated our analyses using pre-pubertal asthma as a negative control
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outcome, and the null results provided further reassurance against pleiotropic mechanisms
independent from pubertal timing.
We used MR methods developed to investigate and adjust for pleiotropy in 2-sample MR,
where estimates of the association of each SNP with risk factor and outcome are derived from
separate studies, and the 2 estimates are assumed independent. The behaviour of these meth-
ods has yet to be studied in the 1-sample context, where independence of the 2 estimates is vio-
lated. However, the consistency of our findings with those derived from the 1-sample 2SLS
method provides reassurance.
Our study is based on self-reported information on doctor-diagnosed asthma, age at men-
arche, and age at voice breaking, which introduces measurement error and potentially recall
bias. However, since it is unlikely that the error in recalling age at puberty would correlate
with the reporting of asthma or asthma AAO, and vice versa, the measurement error is likely
to be random and only result in reduced power. Voice breaking represents the drop in the
pitch of speech due to changes in vocal chords and larynx cartilage in response to androgen
exposure during late puberty [59]. Despite having been suggested as a good marker of pubertal
timing in males when assessed prospectively [60], age at voice breaking is much harder to
recall in adult cross-sectional studies compared with the more clear-cut milestone of menarche
in females, and may be subject to greater measurement error. This is a general problem and
partly explains the limited knowledge about risk factors and effects of early puberty in males,
for which more evidence from longitudinal birth cohort studies is needed. Another limitation
is that we based the choice of MR instruments for age at menarche and, partly, age at voice
breaking on findings from the GWA meta-analysis by Day et al. [16], of which UK Biobank
genetic data (first release only) represented about 20% of the total sample. However, any over-
estimation of the SNP–age at puberty associations resulting from this would have pulled our
MR estimates towards the null, therefore leading to underestimation of the true causal effects
rather than to false positive results. Finally, findings from observational studies might be biased
by “cohort effects” if individuals from younger generations are at different risk of both early
(or late) puberty and asthma compared with older generations. Despite the secular trends of
decreasing age at puberty [45] and increasing prevalence of asthma [1], this type of confound-
ing would not bias the results of our MR study, unless the secular trends also affect the genetic
variants used as instruments for age at puberty, which is unlikely.
In conclusion, we provide evidence for a causal detrimental effect of early puberty on
asthma. Further studies are needed to investigate the mechanisms underlying this effect, and
the similarity of our findings in females and males suggests a possible role for common biolog-
ical or psychological factors accompanying early pubertal development. Taken together with
evidence for other detrimental effects of early puberty on health, our study emphasises the
need to investigate and address causes of the secular shift towards earlier puberty observed
worldwide.
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